StevenHBernsteinMD
Hematology • Rochester, NYProfessor, Medicine, University of Rochester School of Medicine & Dentistry
Are you Dr. Bernstein?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 72 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Box Med
Rochester, NY 14642Phone+1 585-275-0784Fax+1 585-273-5761
Summary
- Dr. Steven Bernstein, MD is a hematologist in Rochester, New York. He is currently licensed to practice medicine in New York. He is affiliated with Highland Hospital and is a Professor at University of Rochester School of Medicine & Dentistry.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1991
University of ChicagoResidency, Internal Medicine, 1984 - 1987
New York University School of MedicineClass of 1984
Certifications & Licensure
NY State Medical License 1985 - 2014
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 27 citationsPhase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphomaPaul M. Barr, Thomas P. Miller, Jonathan W. Friedberg, Derick R. Peterson, Andrea Baran
Blood. 2014-08-21 - 21 citationsIncreased numbers of CD23(+) CD21(hi) Bin-like B cells in human reactive and rheumatoid arthritis lymph nodes.Igor Kuzin, Stephen L. Kates, Yawen Ju, Longze Zhang, Homaira Rahimi
European Journal of Immunology. 2016-05-06 - 851 citationsCharacterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cellsYohei Iwata, Takashi Matsushita, Mayuka Horikawa, David J. DiLillo, Koichi Yanaba
Blood. 2011-01-13
Authored Content
- The Fast Real-Time Assessment of Combination Therapies in Immuno-ONcology (FRACTION) Program: Innovative, High-Throughput Clinical Screening of ImmunotherapiesOctober 2018
